Rice bioengineer looks to mitochondria as key to heart failure recovery
Rice bioengineer Mario Escobar has won a Transformational Project Award from the American Heart Association to develop a new therapy for heart failure.
Rice and Houston Methodist name Chatterjee executive director of the Digital Health Institute
The Digital Health Institute — a recently launched joint initiative between Rice University and Houston Methodist — has appointed Pothik Chatterjee as its executive director, effective May 1.
Cancer Bioengineering Collaborative kicks off seminar series with Nobel laureate James Allison
The Cancer Bioengineering Collaborative launched its inaugural seminar June 3 with an invited talk from Nobel laureate James P. Allison.
Engineered with heart: Student-designed device could streamline imaging for cardiac procedures
A team of six Rice students developed a device that holds and stabilizes an intracardiac echocardiography catheter during heart procedures, allowing the primary physician to maintain precise control of the catheter without needing a second set of hands.
ENRICH Office’s Health Innovations Symposium showcases Rice-TMC biomedical collaboration ecosystem
Rice’s ENRICH Office hosted a two-day symposium April 24-25 at Helix Park highlighting the encompassing range of biomedical research at the university and the network of collaborations with institutions across the Texas Medical Center.
Biotech trailblazers Robert Langer, Robert Ruffolo to headline RBL LLC launch event May 5
The Rice Biotech Launch Pad and RBL LLC will celebrate the official launch and lab opening of RBL LLC May 5 with a program featuring biotech pioneers Robert Langer and Robert Ruffolo.
Rice Biotech Launch Pad and RBL LLC to celebrate official launch and lab opening
The Rice Biotech Launch Pad and RBL LLC will hold an event to celebrate the official launch and lab opening of RBL LLC May 5, following a Rice presidential lecture delivered by Robert Langer Jr. The launch event, held at Helix Park, will also feature a keynote a keynote presentation by Robert Ruffolo Jr.
Rice statistician earns CPRIT award to advance AI-powered precision medicine for prostate cancer
Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of prostate cancer earlier and improve treatment selection.
A recent symposium organized by the ENRICH office and the Rice Neuroengineering Initiative as part of the Meeting of the Minds NeuroNetworking Series explored ethics and policy in brain science today, including in the context of psychedelic-assisted therapy.
Bioengineering students tackle health care disparities through clinical immersion program
Through an eight-week immersive experience, Rice students observed complex clinical environments at Texas Children’s Hospital and the Texas Heart Institute, identifying unmet health care needs and exploring solutions with a human-centered approach.
Rice and UTHealth Houston advancing innovation in translational science
As a partner institution of the Center for Clinical and Translational Sciences at UTHealth Houston, Rice has received approximately $1.69 million in grant funding to support pilot projects, student training and collaborative research in bioengineering, informatics, team science and related areas.
The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic disorders in this vital organ as well as in other organs and tissues.
Rice scientists and collaborators at Baylor College of Medicine have demonstrated a new method for detecting the presence of dangerous chemicals from tobacco smoke in human placentas with unprecedented speed and precision.
Rice labs tapped for brain research by UK funding agency with multimillion-dollar awards
Four Rice research groups are part of an inaugural cohort of 18 projects funded by the U.K.’s Advanced Research and Invention Agency to unlock cutting-edge brain-interfacing technologies.
In Houston’s Texas Medical Center Helix Park, RBL LLC is transforming the path from scientific discovery to lifesaving therapies. This new biotech venture creation studio is designed to rapidly build companies around cutting-edge innovations from Rice University’s Biotech Launch Pad, aiming to bring advanced treatments to patients faster and more efficiently.